MedPath

A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
Registration Number
NCT00421993
Lead Sponsor
Galderma R&D
Brief Summary

This is a multi-center, randomized, double-blind, parallel group study with 12 weeks of treatment of acne vulgaris. Efficacy and safety evaluations will be performed at Screening (safety only), Baseline and Weeks 1, 2, 4, 8 and 12. All Investigator's Global Assessment evaluators and lesion counters must be trained and approved by Galderma. The evaluator of a subject should remain the same during the study.

The primary objective is to demonstrate the superiority in efficacy and assess safety of Adapalene/Benzoyl Peroxide Topical Gel (Adapalene/Benzoyl Peroxide Gel) versus Adapalene Topical Gel, 0.1% (Adapalene Monad); Benzoyl Peroxide Topical Gel, 2.5% (Benzoyl Peroxide Monad) and Topical Gel Vehicle (Gel Vehicle) in the treatment of acne vulgaris for up to 12 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1670
Inclusion Criteria
  • A clinical diagnosis of acne vulgaris with facial involvement.
  • A minimum of 20 but not more than 50 Inflammatory lesions
  • A minimum of 30 but not more than 100 Noninflammatory lesions
  • A score of 3 (Moderate) on the Investigator's Global Assessment Scale.
Exclusion Criteria
  • More than one acne nodule or any acne cyst.
  • Acne conglobata, acne fulminans, secondary acne, or severe acne.
  • Known previous participation in an Adapalene/Benzoyl Peroxide Topical Gel Trial.
  • Underlying diseases that require the use of interfering topical or systemic therapy.
  • Use of prohibited medications prior to the study unless appropriate washout period is documented
  • Use of hormonal contraceptives solely for control of acne

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Adapalene/Benzoyl PeroxideAdapalene/Benzoyl Peroxide Topical Gel
4Topical Gel VehicleTopical Gel Vehicle
2AdapaleneAdapalene Topical Gel
3Benzoyl PeroxideBenzoyl Peroxide Topical Gel
Primary Outcome Measures
NameTimeMethod
Changes in Noninflammatory Lesion Countsfrom Baseline to week 12

Change in Noninflammatory Lesion Counts equals Week 12 Noninflammatory Lesion Count minus Baseline Noninflammatory Lesion Count

Success Rate on the Investigator's Global Assessmentat week 12

Percentage of subjects rated "Clear" and "Almost Clear" on 5-point scale (0=clear; 4=severe)

Changes in Inflammatory Lesion Countsfrom Baseline to week 12

Changes in Inflammatory Lesion Counts equals Week 12 Inflammatory Lesion Counts minus Baseline Inflammatory Lesion Counts

Secondary Outcome Measures
NameTimeMethod
Percent Change in Inflammatory Lesion Countsat week 12

Percent Changes in Inflammatory Lesion Counts equals (Week 12 count minus Baseline count) divided by Baseline count multiplied by 100

Percent Change in Noniflammatory Lesion Countsat week 12

Percent Changes in Noninflammatory Lesion Counts equals (Week 12 count minus Baseline count) divided by Baseline count multiplied by 100

Percent Change in Total Lesion Countsat week 12

Percent Changes in Total Lesion Counts equals (Week 12 count minus Baseline count) divided by Baseline count multiplied by 100

Trial Locations

Locations (61)

UTSW Medical Center at Dallas

🇺🇸

Dallas, Texas, United States

Dawes Fretzin Clinical Research Group, LLC

🇺🇸

Indianapolis, Indiana, United States

Dolby Research, LLC

🇺🇸

Baton Rouge, Louisiana, United States

SKINQRI

🇺🇸

Lincolnshire, Illinois, United States

Associates in research, Inc.

🇺🇸

Fresno, California, United States

Medical Affliated Research Center

🇺🇸

Huntsville, Alabama, United States

Affiliated Research Institute

🇺🇸

San Diego, California, United States

Dermatology Research of Arkansas

🇺🇸

Little Rock, Arkansas, United States

Marcia J. Glenn, MD and Associates, Dermatology & Laser center, Inc

🇺🇸

Marina Del Rey, California, United States

XLR8 Medical Research Inc.

🇨🇦

Windsor, Ontario, Canada

Waldemar Placek

🇵🇱

Bydgoszcz, Poland

Wojceiech Silny

🇵🇱

Poznan, Poland

Dartmouth-Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Dermadvances Research

🇨🇦

Winnipeg, Manitoba, Canada

Atlanta Dermatology and Vein Research Center

🇺🇸

Alpharetta, Georgia, United States

Innovaderm Research Laval Inc.

🇨🇦

Laval, Quebec, Canada

Lynderm Research inc.

🇨🇦

Markham, Ontario, Canada

Allergy, Asthma and Dermatology Research Center, LLC

🇺🇸

Lake Oswego, Oregon, United States

Skin Specialty Group

🇺🇸

New York, New York, United States

Beatrice Gerlach

🇩🇪

Dresden, Germany

Winnipeg Clinic

🇨🇦

Winnipeg, Manitoba, Canada

Zoe Draelos

🇺🇸

High Point, North Carolina, United States

University at San Francisco Medical Center

🇺🇸

San Francisco, California, United States

OU Health Sciences Center - Dept. of Dermatology

🇺🇸

Oklahoma City, Oklahoma, United States

Innovaderm Research Inc

🇨🇦

Montreal, Quebec, Canada

Siena Medical Research

🇨🇦

Montreal, Quebec, Canada

Nexus clinical research

🇨🇦

St. John's, Newfoundland and Labrador, Canada

NewLab Clinical Research

🇨🇦

St. John's, Newfoundland and Labrador, Canada

Henrik Pres

🇩🇪

Berlin, Germany

Otto-Von-Guericke-Universitat Magdeburg

🇩🇪

Magdeburg, Germany

Michael Sebastian

🇩🇪

Mahlow, Germany

University of California, Irvine

🇺🇸

Irvine, California, United States

Meike Schroeder

🇩🇪

Berlin, Germany

Dermatology Research Associates

🇺🇸

Los Angeles, California, United States

Visions Clinical Research

🇺🇸

West Palm Beach, Florida, United States

The George Washington University Medical Center

🇺🇸

Washington, District of Columbia, United States

Hamzavi Dermatology

🇺🇸

Port Huron, Michigan, United States

James Del Rosso, DO - Office of Dr. James Del Russo

🇺🇸

Henderson, Nevada, United States

Somerset Skin Clinic

🇺🇸

Troy, Michigan, United States

Derm Research Center of NY, Inc.

🇺🇸

Stony Brook, New York, United States

Dermatology Associates of Knoxville

🇺🇸

Knoxville, Tennessee, United States

Arlington Center for Dermatology

🇺🇸

Arlington, Texas, United States

Tanner Clinic

🇺🇸

Layton, Utah, United States

The Dermatology Centre

🇨🇦

Calgary, Alberta, Canada

Derm Research @ 888 Inc.

🇨🇦

Vancouver, British Columbia, Canada

Stratica Medical

🇨🇦

Edmonton, Alberta, Canada

Guildford Dermatology Specialists

🇨🇦

Surrey, British Columbia, Canada

Ultranova Skin care

🇨🇦

Barrie, Ontario, Canada

Outpatient Dermatilogy Department XIX District

🇭🇺

Budapest, Hungary

DERMED Specjalistyczne Gabinety Lekarskie

🇵🇱

Lodz, Poland

Thomas Dirschka

🇩🇪

Wuppertal, Germany

Margit Simola

🇭🇺

Budapest, Hungary

Fletcher Allen Health Care

🇺🇸

Burlington, Vermont, United States

Kloverkorn, Windfried

🇩🇪

Gilching, Germany

Dr Weintraub James

🇺🇸

Simi Valley, California, United States

Licca Clinical Research Institute

🇩🇪

Augsburg, Germany

University of Texas Medical Branch at Galveston

🇺🇸

Galveston, Texas, United States

Welborn Clinic

🇺🇸

Evansville, Indiana, United States

North Bay Dermatology Centre

🇨🇦

North Bay, Ontario, Canada

Outpatient Dermatology Department DUH

🇭🇺

Budapest, Hungary

Radiant Research

🇺🇸

Anderson, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath